These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A. Dolimbek BZ, Aoki KR, Steward LE, Jankovic J, Atassi MZ. Mol Immunol; 2007 Feb; 44(5):1029-41. PubMed ID: 16647121 [Abstract] [Full Text] [Related]
48. International conference on equine grass sickness, Dubai, United Arab Emirates September 22-23, 2001. Timoney PJ, Wernery U. Vet J; 2003 Jan; 165(1):7-10. PubMed ID: 12618064 [No Abstract] [Full Text] [Related]
49. [Anaphylactogenic, antigeni and avid properties of the antibotulin serum from the blood of various animal species]. Sinel'nikov GE, Preger SM, Muzafarova NKh. Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):123-7. PubMed ID: 343452 [Abstract] [Full Text] [Related]
50. Antibodies to Clostridium botulinum toxins in free-living birds and mammals. Ohishi I, Sakaguchi G, Riemann H, Behymer D, Hurvell B. J Wildl Dis; 1979 Jan; 15(1):3-9. PubMed ID: 459044 [Abstract] [Full Text] [Related]
51. A nationwide surveillance scheme for equine grass sickness in Great Britain: results for the period 2000-2009. Wylie CE, Proudman CJ, McGorum BC, Newton JR. Equine Vet J; 2011 Sep; 43(5):571-9. PubMed ID: 21649713 [Abstract] [Full Text] [Related]
53. [The antigenic structure of the toxins of Clostridium botulinum, type C strains, isolated in the USSR]. Bulatova TI, Matveev KI. Zh Mikrobiol Epidemiol Immunobiol; 1965 Aug; 42(8):79-84. PubMed ID: 5334428 [No Abstract] [Full Text] [Related]
54. Clinical use of botulinum neurotoxins. Cardoso F, Jankovic J. Curr Top Microbiol Immunol; 1995 Aug; 195():123-41. PubMed ID: 8542751 [No Abstract] [Full Text] [Related]
55. [Immunochemical and biological characteristics of type A botulinum toxoids. II]. Drachennikov VI, Golshmid VK, Rezepov FF, Chentsova OI. Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):12-8. PubMed ID: 4941809 [No Abstract] [Full Text] [Related]
57. [Contribution to the study of bacterial hemolysins; properties of C and D types of botulinus toxins]. GUILLAUMIE M, KREGUER A. C R Seances Soc Biol Fil; 1951 Feb; 145(3-4):179-82. PubMed ID: 14839916 [No Abstract] [Full Text] [Related]
58. Different pH optima in the two steps of an indirect fluorescent antibody reaction for Clostridium botulinum type E. Robohm RA. Appl Microbiol; 1974 Jan; 27(1):179-84. PubMed ID: 4589127 [Abstract] [Full Text] [Related]
59. [Analysis of physiological basis of so-called depression immunity. I. Effect of homo- and heterological bacterial antigenic irritations and of non-specific stimuli on manifestation of depression immunity]. KRYLOV VN. Zh Mikrobiol Epidemiol Immunobiol; 1958 Jun; 29(6):69-74. PubMed ID: 13570544 [No Abstract] [Full Text] [Related]
60. Edaphic and Phytochemical Factors as Predictors of Equine Grass Sickness Cases in the UK. Edwards SE, Martz KE, Rogge A, Heinrich M. Front Pharmacol; 2010 Jun; 1():122. PubMed ID: 21833167 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]